Bot Security Market

Bot Security Market

Bot Security Market Study offers authentic data and exhaustive analysis of the virtual security ecosystem. Based on a well-founded methodology, the study arrives at the market size and growth numbers using unique DB Forecasting Model that gives varied weightage to all frames of market influencers such as DROCs, Industry Trends, PESTLE, Competitive Landscape, Latest Developments and our primary probes. The study covers Bot Security providers, software compliance, technology providers, in addition to, robustly ranking the leading market players, and forecasting their growth on basis of their activities, revenues, offerings, partnerships and other multiple parameters. Major players are profiled in the report such as Akamai Technologies (US), Imperva (US), PerimeterX (US), Cloudflare (US), Radware (Israel), Fastly (US), F5 (US), Sophos (UK), Reblaze (Israel), Netacea (UK), DataDome (France), Shape Security (US), AppsFlyer (US), Alibaba Cloud (China), SecuCloud (Germany), and others. In this extensive seven-year study, from 2020-2026, we track the multiple segments such as by Component (Standalone Solution, Services), Security Type (Web, Mobile, API), Deployment Mode, Organization Size, Vertical (Retail & E-commerce, Media and Entertainment, Travel and Hospitality), and Region (country, while providing reasons for each of these segments’ size and growth rate). The social media apps such as Facebook, Instagram, and Snapchat as well as digital entertainment platforms such as Netflix and Amazon Prime are also making smartphone users spend more time on their devices. Due to this, the web traffic is shifted from web to mobile, making them prone to botnet attacks. North America is estimated to account for the major market size in the Bot Security market during the forecast period. The report contains relevant figures and tables in a ready-to-use format. Please fill the form for a detailed ToC, Sample and Executive Summary. Custom demand for exclusive sections/countries is available.
TBD
QnQ MRI